First Time Loading...

Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.006 AUD Market Closed
Updated: May 10, 2024

Intrinsic Value

BXN doesn't have a meaningful market cap.

Bioxyne Ltd. engages in the research, development, market and distribution of health products. [ Read More ]

The intrinsic value of one BXN stock under the Base Case scenario is 0.006 AUD. Compared to the current market price of 0.006 AUD, Bioxyne Ltd is Fairly Valued.

Key Points:
BXN Intrinsic Value
Base Case
0.006 AUD
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bioxyne Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BXN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Bioxyne Ltd

Provide an overview of the primary business activities
of Bioxyne Ltd.

What unique competitive advantages
does Bioxyne Ltd hold over its rivals?

What risks and challenges
does Bioxyne Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioxyne Ltd.

Provide P/S
for Bioxyne Ltd.

Provide P/E
for Bioxyne Ltd.

Provide P/OCF
for Bioxyne Ltd.

Provide P/FCFE
for Bioxyne Ltd.

Provide P/B
for Bioxyne Ltd.

Provide EV/S
for Bioxyne Ltd.

Provide EV/GP
for Bioxyne Ltd.

Provide EV/EBITDA
for Bioxyne Ltd.

Provide EV/EBIT
for Bioxyne Ltd.

Provide EV/OCF
for Bioxyne Ltd.

Provide EV/FCFF
for Bioxyne Ltd.

Provide EV/IC
for Bioxyne Ltd.

Compare the intrinsic valuations
of Bioxyne Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioxyne Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioxyne Ltd compared to its peers.

Compare the P/E ratios
of Bioxyne Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioxyne Ltd with its peers.

Analyze the financial leverage
of Bioxyne Ltd compared to its main competitors.

Show all profitability ratios
for Bioxyne Ltd.

Provide ROE
for Bioxyne Ltd.

Provide ROA
for Bioxyne Ltd.

Provide ROIC
for Bioxyne Ltd.

Provide ROCE
for Bioxyne Ltd.

Provide Gross Margin
for Bioxyne Ltd.

Provide Operating Margin
for Bioxyne Ltd.

Provide Net Margin
for Bioxyne Ltd.

Provide FCF Margin
for Bioxyne Ltd.

Show all solvency ratios
for Bioxyne Ltd.

Provide D/E Ratio
for Bioxyne Ltd.

Provide D/A Ratio
for Bioxyne Ltd.

Provide Interest Coverage Ratio
for Bioxyne Ltd.

Provide Altman Z-Score Ratio
for Bioxyne Ltd.

Provide Quick Ratio
for Bioxyne Ltd.

Provide Current Ratio
for Bioxyne Ltd.

Provide Cash Ratio
for Bioxyne Ltd.

What is the historical Revenue growth
over the last 5 years for Bioxyne Ltd?

What is the historical Net Income growth
over the last 5 years for Bioxyne Ltd?

What is the current Free Cash Flow
of Bioxyne Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioxyne Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bioxyne Ltd

Current Assets 4.7m
Cash & Short-Term Investments 1.5m
Receivables 1.3m
Other Current Assets 1.9m
Non-Current Assets 71.3k
PP&E 71.3k
Current Liabilities 2.1m
Accounts Payable 2m
Other Current Liabilities 78.9k
Non-Current Liabilities -221.7k
Other Non-Current Liabilities -221.7k
Efficiency

Earnings Waterfall
Bioxyne Ltd

Revenue
8.7m AUD
Cost of Revenue
-5.3m AUD
Gross Profit
3.3m AUD
Operating Expenses
-6.4m AUD
Operating Income
-3.1m AUD
Other Expenses
-11m AUD
Net Income
-14.2m AUD

Free Cash Flow Analysis
Bioxyne Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BXN Profitability Score
Profitability Due Diligence

Bioxyne Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Declining ROE
25/100
Profitability
Score

Bioxyne Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

BXN Solvency Score
Solvency Due Diligence

Bioxyne Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
63/100
Solvency
Score

Bioxyne Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BXN Price Targets Summary
Bioxyne Ltd

There are no price targets for BXN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BXN Price
Bioxyne Ltd

1M 1M
-33%
6M 6M
-45%
1Y 1Y
-76%
3Y 3Y
-74%
5Y 5Y
-65%
10Y 10Y
-63%
Annual Price Range
0.006
52w Low
0.006
52w High
0.025
Price Metrics
Average Annual Return 27.69%
Standard Deviation of Annual Returns 90.69%
Max Drawdown -83%
Shares Statistics
Market Capitalization 11.4m AUD
Shares Outstanding 1 901 650 048
Percentage of Shares Shorted
N/A

BXN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Bioxyne Ltd Logo
Bioxyne Ltd

Country

Australia

Industry

Consumer products

Market Cap

11.4m AUD

Dividend Yield

0%

Description

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

Contact

NEW SOUTH WALES
Sydney
Se 506 L 5, 50 Clarence Street
+61290788180.0
http://www.bioxyne.com/

IPO

2000-12-14

Employees

-

Officers

CEO, MD & Executive Director
Mr. Samuel Watson
CFO & Company Secretary
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD
COO & Executive Director
Mr. Jason Hine
Financial Controller & Assistant Company Secretary
Ms. Rachel Qian

See Also

Discover More
What is the Intrinsic Value of one BXN stock?

The intrinsic value of one BXN stock under the Base Case scenario is 0.006 AUD.

Is BXN stock undervalued or overvalued?

Compared to the current market price of 0.006 AUD, Bioxyne Ltd is Fairly Valued.